Jones, Robert M.,Han, Sangdon,Buzard, Daniel J.,Lehmann, Juerg,Narayanan, Sanju,Yue, Dawei
申请号：
AU2011237775
公开号：
AU2011237775A1
申请日:
2011.04.05
申请国别(地区):
AU
年份:
2012
代理人:
摘要：
The present invention relates to compounds of Formula (Ia) and pharmaceutically acceptable salts, solvates, and hydrates thereof, that are useful as a single agent or in combination with one or more additional pharmacetical agents, such as, an inhibitor of DPP-IV, a biguanide, an SGLT2 inhibitor, or an alpha-glucosidase inhibitor, in the treatment of, for example, a disorder selected from: a GPR119-receptor-related disorder； a condition ameliorated by increasing a blood incretin level； a metabolic-related disorder； type 2 diabetes； obesity； and complications related thereto.
